These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2127558

  • 1. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
    Doern GV, Tubert TA.
    Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV.
    Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G, Aleo G, Caccamo F, Nicolosi VM, Siracusa V, Speciale A.
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of BAY v 3522, a new oral cephalosporin.
    Fass RJ.
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1855-7. PubMed ID: 2126697
    [Abstract] [Full Text] [Related]

  • 5. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE, Slocombe B, White AR.
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [Abstract] [Full Text] [Related]

  • 6. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R, Jiménez Arriero M, Rodriguez-Tudela JL, Soriano F.
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO, Gezelius L.
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
    Nash DR, Flanagan C, Steele LC, Wallace RJ.
    Antimicrob Agents Chemother; 1991 Jan; 35(1):192-4. PubMed ID: 1901696
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV, Vautour R.
    Diagn Microbiol Infect Dis; 1992 Jan; 15(7):633-40. PubMed ID: 1424521
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
    Chin NX, Gu JW, Neu HC.
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
    [Abstract] [Full Text] [Related]

  • 11. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [Abstract] [Full Text] [Related]

  • 12. In vitro studies with Bay V 3522, a new oral cephalosporin.
    Thomson KS, Sanders CC, Sanders WE.
    Drugs Exp Clin Res; 1991 Jun; 17(3):165-73. PubMed ID: 1914843
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G.
    Chemotherapy; 1992 Jun; 38(1):36-45. PubMed ID: 1618002
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [Abstract] [Full Text] [Related]

  • 15. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 16. Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countries.
    Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA, Bouchillon SK, Hoban DJ.
    Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):55-60. PubMed ID: 11245326
    [Abstract] [Full Text] [Related]

  • 17. Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
    Bingen E, Bourgeois F, Chardon H, Doit C, Lambert-Zechovsky N.
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):923-6. PubMed ID: 1486888
    [Abstract] [Full Text] [Related]

  • 18. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL, Fuchs PC, Pfaller MA.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [Abstract] [Full Text] [Related]

  • 19. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K, Jakoniuk P, Sacha PT, Zalewska M, Wieczorek P.
    Med Dosw Mikrobiol; 2004 Jan; 56(3):231-7. PubMed ID: 15773499
    [Abstract] [Full Text] [Related]

  • 20. [Serotype distribution and drug resistance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from nasopharynx of Uygur children].
    Tian HL, Shi W, Zhou HF, Yuan L, Yao KH, Rexiati D, Xu AM.
    Zhonghua Er Ke Za Zhi; 2018 Apr 02; 56(4):279-283. PubMed ID: 29614568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.